VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $7,701,000 | -13.5% | 53,811 | -20.7% | 0.00% | -33.3% |
Q3 2014 | $8,902,000 | -2.8% | 67,854 | -6.5% | 0.00% | 0.0% |
Q2 2014 | $9,156,000 | +8.6% | 72,599 | +13.5% | 0.00% | +50.0% |
Q1 2014 | $8,432,000 | -6.0% | 63,959 | -16.3% | 0.00% | -33.3% |
Q4 2013 | $8,967,000 | +14.7% | 76,376 | +1.9% | 0.00% | 0.0% |
Q3 2013 | $7,821,000 | +10.0% | 74,962 | -9.2% | 0.00% | 0.0% |
Q2 2013 | $7,110,000 | – | 82,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |